Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue-Reference-Cited by-同舟云学术

Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue

Published:2020-08-17 Issue:12 Volume:94 Page:4037-4041
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Saheb Sharif-Askari Narjes,Saheb Sharif-Askari Fatemeh,Mdkhana Bushra,Al Heialy Saba,Ratemi Elaref,Alghamdi Malak,Abusnana Salah,Kashour Tarek,Hamid Qutayba,Halwani Rabih^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00204-020-02869-1.pdf

Reference26 articles.

1. Alsaad KO et al (2018) Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection—clinicopathological and ultrastructural study. Histopathology 72:516–524. https://doi.org/10.1111/his.13379

2. Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, Rogiers V (2020) COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? Arch Toxicol. https://doi.org/10.1007/s00204-020-02734-1

3. Chau TN et al (2004) SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 39:302–310. https://doi.org/10.1002/hep.20111

4. Clarke NE, Belyaev ND, Lambert DW, Turner AJ (2014) Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress. Clin Sci (Lond) 126:507–516. https://doi.org/10.1042/cs20130291

5. Dudoit S, Yang YH, Callow MJ, Speed TP (2002) Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Stat Sin 12:111–139

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Common Anti-Inflammatories on Adenovirus Entry and Their Physicochemical Properties: An In-Depth Study Using Cellular and Animal Models;Microbiology Research;2024-08-19

2. The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7;Cardiovascular Diabetology;2024-01-09

3. COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups;Liver Research;2023-09

4. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents;The Lancet Infectious Diseases;2023-01

5. Protection by metformin against severe Covid-19: An in-depth mechanistic analysis;Diabetes & Metabolism;2022-07